Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001129928-25-000019
Filing Date
2025-03-07
Accepted
2025-03-07 12:48:58
Documents
110
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 20-F oncyf-20241231.htm   iXBRL 20-F 1764124
2 EX-2.1 ex21exdescriptionofsecurit.htm EX-2.1 3132
3 EX-8.0 ex80subsidiaries2024.htm EX-8.0 3521
4 EX-12.1 ex121ceocertification2024.htm EX-12.1 10187
5 EX-12.2 ex122cfocertification2024.htm EX-12.2 10157
6 EX-13.1 ex131ceocertification2024.htm EX-13.1 4992
7 EX-13.2 ex132cfocertification2024.htm EX-13.2 4643
8 EX-15.1 ex151-2024mda.htm EX-15.1 349719
9 EX-15.2 ex152ey2024consent.htm EX-15.2 4642
15 oncolyticslogotaglineblueaa.jpg GRAPHIC 367326
16 pipelinea.jpg GRAPHIC 527195
17 oncyf-20241231_g1.jpg GRAPHIC 148102
18 oncyf-20241231_g2.jpg GRAPHIC 460603
  Complete submission text file 0001129928-25-000019.txt   11157998

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncyf-20241231.xsd EX-101.SCH 75815
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oncyf-20241231_cal.xml EX-101.CAL 48712
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oncyf-20241231_def.xml EX-101.DEF 275458
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncyf-20241231_lab.xml EX-101.LAB 604507
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncyf-20241231_pre.xml EX-101.PRE 450959
113 EXTRACTED XBRL INSTANCE DOCUMENT oncyf-20241231_htm.xml XML 1159843
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38512 | Film No.: 25718731
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)